Skip to main content
OpenTrials

Clinical trial condition

Neoplasm Metastasis

Explore clinical trials studying Neoplasm Metastasis. Study availability and eligibility vary by location and protocol.

2,438 public trials 498 recruiting studies
Refine in advanced search Browse all conditions

Neoplasm Metastasis trial results

Completed

Cytoreductive Prostatectomy Versus Cytoreductive Prostate Irradiation As a Local Treatment Option for Metastatic Prostate Cancer: a Multicentric Feasibility Trial

NCT03655886

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +12 more
Locations
  • Antwerp University Hospital Edegem, Antwerp, Belgium
  • AZ Jan Palfijn Ghent, East Flanders, Belgium
  • Leuven University Hospital Leuven, Flemish Brabant, Belgium
  • AZ Maria Middelares Ghent, Belgium
View Trial Details
Completed

Efficacy Assessment of Lenvatinib Associated with Pembrolizumab in Metastatic Endometrial Cancer: a French Multicentric Retrospective Early Access Program-based Study

NCT06599463

Conditions
Endometrial Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations
  • ICO Paul Papin Angers, France
  • Sainte Catherine - Institut du Cancer Avignon Avignon, France
  • CHU Jean Minjoz Besançon, France
  • ICONE Bezannes, France
View all 24 locations
View Trial Details
Completed

Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer

NCT02492711

Conditions
HER-2 Positive Breast Cancer, Metastatic Neoplasm, Neoplasm Metastasis, +4 more
Locations
  • Ironwood Cancer & Research Center Chandler, Arizona, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Western Regional Medical Center, Inc. Goodyear, Arizona, United States
  • East Valley Hematology And Oncology Burbank, California, United States
View all 167 locations
View Trial Details
Completed

A Study of Etigilimab and Nivolumab in Participants With Locally Advanced or Metastatic Tumors

NCT04761198

Conditions
Advanced Solid Tumor, Metastatic Solid Tumor, Neoplasm Metastasis, +5 more
Locations
  • Mereo Investigator Site Phoenix, Arizona, United States
  • Mereo Investigator Site Greenbrae, California, United States
  • Mereo Investigator Site Los Angeles, California, United States
  • Mereo Investigator Site Jacksonville, Florida, United States
View all 16 locations
View Trial Details
Completed

PAKT: AZD5363 in Combination With Paclitaxel in Triple-Negative Advanced or Metastatic Breast Cancer

NCT02423603

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +9 more
Locations
  • ICO René Gauducheau Nantes, France
  • Centre André-lacassagne Nice, France
  • Centre Hospitalier Prive Saint-Gregoire Saint-Grégoire, France
  • Institute of Clinical Oncology Tbilisi, Georgia
View all 46 locations
View Trial Details
Completed

Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination

NCT02636855

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +7 more
Locations
  • City of Hope Duarte, California, United States
  • Stanford Cancer Institute (Stanford University) Stanford, California, United States
  • Boca Raton Regional Hospital, Lynn Cancer Institute, 701 NW 13th Street Boca Raton, Florida, United States
  • University of Miami, Sylvester Comprehensive Cancer Center Miami, Florida, United States
View all 36 locations
View Trial Details
Completed

NAP in Combination With Docetaxel Following Obinutuzumab Pretreatment in Subjects With Checkpoint Inhibitor Pretreated Advanced or Metastatic NSCLC

NCT04880863

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • NeoTX - 10307 Daphne, Alabama, United States
  • NeoTX - 10302 Scottsdale, Arizona, United States
  • NeoTX - 10303 Tucson, Arizona, United States
  • NeoTX - 10306 Lone Tree, Colorado, United States
View Trial Details

Related conditions